Groupe la Francaise Purchases New Position in Select Medical Holdings Corporation $SEM

Groupe la Francaise purchased a new stake in shares of Select Medical Holdings Corporation (NYSE:SEM) in the first quarter, Holdings Channel.com reports. The institutional investor purchased 282,497 shares of the health services provider’s stock, valued at approximately $4,602,000.

A number of other large investors have also recently made changes to their positions in SEM. Dana Investment Advisors Inc. raised its holdings in shares of Select Medical by 29.3% during the fourth quarter. Dana Investment Advisors Inc. now owns 678,545 shares of the health services provider’s stock valued at $10,076,000 after acquiring an additional 153,924 shares in the last quarter. Penn Capital Management Company LLC purchased a new position in Select Medical during the 4th quarter valued at $1,914,000. OP Asset Management Ltd bought a new position in Select Medical in the 1st quarter worth $1,661,000. Western Standard LLC lifted its position in shares of Select Medical by 95.6% in the 4th quarter. Western Standard LLC now owns 2,064,021 shares of the health services provider’s stock worth $30,651,000 after purchasing an additional 1,008,664 shares during the period. Finally, Tudor Investment Corp ET AL purchased a new stake in shares of Select Medical in the 3rd quarter worth about $1,466,000. 89.48% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on SEM shares. Weiss Ratings upgraded shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Mizuho restated a “neutral” rating and issued a $16.50 price objective (down from $17.00) on shares of Select Medical in a report on Tuesday, May 12th. Finally, Zacks Research raised Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $15.50.

Select Medical Stock Performance

Select Medical stock opened at $16.51 on Friday. Select Medical Holdings Corporation has a twelve month low of $11.65 and a twelve month high of $16.99. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $2.05 billion, a P/E ratio of 15.58, a PEG ratio of 0.95 and a beta of 1.01. The stock’s 50 day moving average is $16.54 and its 200 day moving average is $16.18.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter in the previous year, the firm posted $0.44 EPS. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, equities research analysts predict that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.